UK extends PGD (prenatal genetic diagnosis) embryo screening to FAP (familial adenomatous polyposis) colorectal cancer
This article was originally published in Clinica
Executive Summary
The UK's Human Fertilisation and Embryology Authority (HFEA) has approved the use of prenatal genetic diagnosis (PGD) to screen IVF embryos for familial adenomatous polyposis coli (FAP). A licence has been awarded to Dr Paul Serhal, of London's University College Hospital.